Logo image of BRE.CA

BRIDGEMARQ REAL ESTATE SERVI (BRE.CA) Stock Fundamental Analysis

TSX:BRE - Toronto Stock Exchange - CA10808B1085 - Common Stock - Currency: CAD

13.76  -0.07 (-0.51%)

Fundamental Rating

5

BRE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 30 industry peers in the Real Estate Management & Development industry. There are concerns on the financial health of BRE while its profitability can be described as average. BRE has a correct valuation and a medium growth rate. Finally BRE also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BRE had negative earnings in the past year.
BRE had a positive operating cash flow in the past year.
Each year in the past 5 years BRE has been profitable.
In the past 5 years BRE always reported a positive cash flow from operatings.
BRE.CA Yearly Net Income VS EBIT VS OCF VS FCFBRE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.97%, BRE is in line with its industry, outperforming 51.72% of the companies in the same industry.
BRE has a better Return On Invested Capital (70.65%) than 100.00% of its industry peers.
BRE had an Average Return On Invested Capital over the past 3 years of 222.44%. This is significantly above the industry average of 7.11%.
The 3 year average ROIC (222.44%) for BRE is well above the current ROIC(70.65%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -1.97%
ROE N/A
ROIC 70.65%
ROA(3y)13.7%
ROA(5y)9.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)222.44%
ROIC(5y)138.3%
BRE.CA Yearly ROA, ROE, ROICBRE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400 600

1.3 Margins

BRE's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 7.14%, BRE is doing worse than 72.41% of the companies in the same industry.
BRE's Operating Margin has declined in the last couple of years.
BRE's Gross Margin of 98.22% is amongst the best of the industry. BRE outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of BRE has remained more or less at the same level.
Industry RankSector Rank
OM 7.14%
PM (TTM) N/A
GM 98.22%
OM growth 3Y4.1%
OM growth 5Y-8.83%
PM growth 3Y62.89%
PM growth 5Y-27.57%
GM growth 3Y-0.12%
GM growth 5YN/A
BRE.CA Yearly Profit, Operating, Gross MarginsBRE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BRE is creating value.
BRE has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for BRE remains at a similar level compared to 5 years ago.
BRE has a worse debt/assets ratio than last year.
BRE.CA Yearly Shares OutstandingBRE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
BRE.CA Yearly Total Debt VS Total AssetsBRE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -0.13, we must say that BRE is in the distress zone and has some risk of bankruptcy.
BRE has a worse Altman-Z score (-0.13) than 79.31% of its industry peers.
The Debt to FCF ratio of BRE is 5.20, which is a neutral value as it means it would take BRE, 5.20 years of fcf income to pay off all of its debts.
BRE's Debt to FCF ratio of 5.20 is amongst the best of the industry. BRE outperforms 82.76% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.2
Altman-Z -0.13
ROIC/WACC8.31
WACC8.5%
BRE.CA Yearly LT Debt VS Equity VS FCFBRE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

2.3 Liquidity

BRE has a Current Ratio of 0.40. This is a bad value and indicates that BRE is not financially healthy enough and could expect problems in meeting its short term obligations.
BRE has a Current ratio of 0.40. This is in the lower half of the industry: BRE underperforms 72.41% of its industry peers.
BRE has a Quick Ratio of 0.40. This is a bad value and indicates that BRE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.40, BRE is not doing good in the industry: 72.41% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.4
BRE.CA Yearly Current Assets VS Current LiabilitesBRE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

6

3. Growth

3.1 Past

The earnings per share for BRE have decreased strongly by -210.50% in the last year.
The earnings per share for BRE have been decreasing by -35.66% on average. This is quite bad
BRE shows a strong growth in Revenue. In the last year, the Revenue has grown by 440.05%.
Measured over the past years, BRE shows a small growth in Revenue. The Revenue has been growing by 2.89% on average per year.
EPS 1Y (TTM)-210.5%
EPS 3Y35.72%
EPS 5Y-35.66%
EPS Q2Q%-269.78%
Revenue 1Y (TTM)440.05%
Revenue growth 3Y6.3%
Revenue growth 5Y2.89%
Sales Q2Q%890.71%

3.2 Future

BRE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.85% yearly.
The Revenue is expected to grow by 1149.58% on average over the next years. This is a very strong growth
EPS Next Y445.4%
EPS Next 2Y-2.91%
EPS Next 3Y51.85%
EPS Next 5YN/A
Revenue Next Year148115%
Revenue Next 2Y4168.75%
Revenue Next 3Y1149.58%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BRE.CA Yearly Revenue VS EstimatesBRE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20B 40B 60B 80B
BRE.CA Yearly EPS VS EstimatesBRE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

5

4. Valuation

4.1 Price/Earnings Ratio

BRE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 97.31, the valuation of BRE can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as BRE.
When comparing the Price/Forward Earnings ratio of BRE to the average of the S&P500 Index (22.68), we can say BRE is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 97.31
BRE.CA Price Earnings VS Forward Price EarningsBRE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BRE is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, BRE is valued cheaper than 89.66% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.71
EV/EBITDA 6.94
BRE.CA Per share dataBRE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

BRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BRE's earnings are expected to grow with 51.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.91%
EPS Next 3Y51.85%

8

5. Dividend

5.1 Amount

BRE has a Yearly Dividend Yield of 9.76%, which is a nice return.
BRE's Dividend Yield is rather good when compared to the industry average which is at 3.36. BRE pays more dividend than 96.55% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, BRE pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.76%

5.2 History

The dividend of BRE has a limited annual growth rate of 0.02%.
BRE has paid a dividend for at least 10 years, which is a reliable track record.
BRE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.02%
Div Incr Years0
Div Non Decr Years12
BRE.CA Yearly Dividends per shareBRE.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of BRE are negative and hence is the payout ratio. BRE will probably not be able to sustain this dividend level.
BRE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-398.29%
EPS Next 2Y-2.91%
EPS Next 3Y51.85%
BRE.CA Yearly Income VS Free CF VS DividendBRE.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

BRIDGEMARQ REAL ESTATE SERVI

TSX:BRE (2/21/2025, 7:00:00 PM)

13.76

-0.07 (-0.51%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)03-14 2025-03-14
Inst Owners0.27%
Inst Owner ChangeN/A
Ins Owners0.89%
Ins Owner ChangeN/A
Market Cap130.44M
Analysts80
Price Target18.36 (33.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 9.76%
Yearly Dividend1.35
Dividend Growth(5Y)0.02%
DP-398.29%
Div Incr Years0
Div Non Decr Years12
Ex-Date01-31 2025-01-31 (0.1125)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.56%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 97.31
P/S 0.5
P/FCF 7.71
P/OCF 7.25
P/B N/A
P/tB N/A
EV/EBITDA 6.94
EPS(TTM)-0.78
EYN/A
EPS(NY)0.14
Fwd EY1.03%
FCF(TTM)1.78
FCFY12.97%
OCF(TTM)1.9
OCFY13.79%
SpS27.37
BVpS-7.27
TBVpS-14.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.97%
ROE N/A
ROCE 100.46%
ROIC 70.65%
ROICexc 206.57%
ROICexgc N/A
OM 7.14%
PM (TTM) N/A
GM 98.22%
FCFM 6.52%
ROA(3y)13.7%
ROA(5y)9.04%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)222.44%
ROIC(5y)138.3%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)316.27%
ROCE(5y)196.63%
ROICexcg growth 3Y3.73%
ROICexcg growth 5Y-2.47%
ROICexc growth 3Y22.86%
ROICexc growth 5Y2.92%
OM growth 3Y4.1%
OM growth 5Y-8.83%
PM growth 3Y62.89%
PM growth 5Y-27.57%
GM growth 3Y-0.12%
GM growth 5YN/A
F-Score5
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.2
Debt/EBITDA 2.86
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.49
Cash Conversion 60.49%
Profit Quality N/A
Current Ratio 0.4
Quick Ratio 0.4
Altman-Z -0.13
F-Score5
WACC8.5%
ROIC/WACC8.31
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)244%
Profit Quality(5y)731.21%
High Growth Momentum
Growth
EPS 1Y (TTM)-210.5%
EPS 3Y35.72%
EPS 5Y-35.66%
EPS Q2Q%-269.78%
EPS Next Y445.4%
EPS Next 2Y-2.91%
EPS Next 3Y51.85%
EPS Next 5YN/A
Revenue 1Y (TTM)440.05%
Revenue growth 3Y6.3%
Revenue growth 5Y2.89%
Sales Q2Q%890.71%
Revenue Next Year148115%
Revenue Next 2Y4168.75%
Revenue Next 3Y1149.58%
Revenue Next 5YN/A
EBIT growth 1Y-0.87%
EBIT growth 3Y10.66%
EBIT growth 5Y-6.2%
EBIT Next Year165862%
EBIT Next 3Y1196.12%
EBIT Next 5YN/A
FCF growth 1Y11.23%
FCF growth 3Y-9.89%
FCF growth 5Y10.81%
OCF growth 1Y18.23%
OCF growth 3Y-11.73%
OCF growth 5Y-6.35%